Yosaatmadja, Yuliana <br/><br/>
Binding mode of the breakthrough inhibitor AZD9291 to epidermal growth factor receptor revealed.  [electronic resource] 

 -  Journal of structural biology  Dec 2015 
 - 539-544 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1095-8657 
<br/><br/><label>Standard No.: </label>10.1016/j.jsb.2015.10.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acrylamides--metabolism<br/>Aniline Compounds--metabolism<br/>Antineoplastic Agents--pharmacology<br/>Crystallography, X-Ray<br/>Drug Resistance, Neoplasm--genetics<br/>ErbB Receptors--antagonists & inhibitors<br/>Erlotinib Hydrochloride--pharmacology<br/>Gefitinib<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Protein Binding--physiology<br/>Protein Kinase Inhibitors--pharmacology<br/>Quinazolines--pharmacology